Globus Medical, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $763.7 million (-0.7% year over year) and diluted EPS of $1.04. It usually reports 7–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 6, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Jan 7, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 7–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
36 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
764
-0.7%
|
141
+18.7%
|
1.04
+18.2%
|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
790
+5.9%
|
152
-25.3%
|
1.10
-26.2%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
760
+27.0%
|
124
+64.7%
|
0.90
+66.7%
|
|
Jan 7, 2026
7 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
826
+25.7%
|
141
+430.4%
|
1.03
+442.6%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
769
+22.9%
|
119
+129.5%
|
0.88
+131.6%
|
|
Jul 21, 2025
21 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
745
+18.4%
|
203
+538.7%
|
1.49
+547.8%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
598
-1.4%
|
75
+1160.3%
|
0.54
+1180.0%
|
|
Jan 8, 2025
8 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
657
+6.6%
|
27
+76.3%
|
0.19
+61.7%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GMED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Audubon, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1237831
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.